Patents Assigned to Miracor Medical Systems GmbH
  • Patent number: 9855049
    Abstract: Some embodiments of a system or method for treating heart tissue can include a control system and catheter device operated in a manner to intermittently occlude a heart vessel for controlled periods of time that provide redistribution of blood flow. In particular embodiments, the system can be configured to provide an estimation of the cumulative effects of the treatment. For example, some embodiments of the system or method can treat myocardium that is at risk of infarction by intermittently altering blood flow in a venous system to induce microcirculation within the myocardium, and can output a cumulative dosage value indicative of a measurement of progress of reducing an infarct size.
    Type: Grant
    Filed: December 11, 2013
    Date of Patent: January 2, 2018
    Assignee: Miracor Medical Systems GmbH
    Inventors: Lars Roman Schiemanck, Martin Haidacher
  • Patent number: 9724102
    Abstract: In a method for intermittently occluding the coronary sinus, in which the coronary sinus is occluded using an occlusion device, the fluid pressure in the occluded coronary sinus is continuously measured and stored, the fluid pressure curve is determined as a function of time, and the occlusion of the coronary sinus is triggered and/or released as a function of at least one characteristic value derived from the measured pressure values. The pressure increase and/or pressure decrease per time unit each occurring at a heart beat are used as characteristic values.
    Type: Grant
    Filed: July 28, 2014
    Date of Patent: August 8, 2017
    Assignee: Miracor Medical Systems GmbH
    Inventors: Werner Mohl, Loay Alzubaidi
  • Patent number: 9439600
    Abstract: Some embodiments of a system or method for treating heart tissue can include a catheter device that provides a user with the ability to perform a number of heart treatment tasks (before, during, and after a cardiac surgery or a percutaneous coronary intervention). In particular embodiments, the catheter device can be used to (i) precondition heart muscle tissue before the heart is isolated from the circulatory system, (ii) deliver cardioplegia into the coronary sinus during the cardiac surgery when the heart is isolated from the circulatory system, and (iii) control the blood flow through the heart after the heart is reconnected with the circulatory system. In some embodiments, the catheter device can perform some or all of: (i) intermittently occluding the coronary sinus, (ii) delivering a treatment fluid into the coronary sinus, and (iii) monitoring a flow rate of blood passing from the coronary sinus to the right atrium.
    Type: Grant
    Filed: August 5, 2013
    Date of Patent: September 13, 2016
    Assignee: Miracor Medical Systems GmbH
    Inventor: Werner Mohl
  • Patent number: 9433381
    Abstract: Some embodiments of a system or method for treating heart tissue can include a control system and catheter device operated in a manner to intermittently occlude a heart vessel for controlled periods of time that provide redistribution of blood flow. In particular embodiments, the system and methods may be configured to monitor at least one input signal detected at a coronary sinus and thereby execute a process for determining a satisfactory time period for the occlusion of the coronary sinus. In further embodiments, after the occlusion of the coronary sinus is released, the control system can be configured to select the duration of the release phase before the starting the next occlusion cycle.
    Type: Grant
    Filed: December 23, 2011
    Date of Patent: September 6, 2016
    Assignee: Miracor Medical Systems GmbH
    Inventors: Werner Mohl, Gregor Neumayr, Alem Jusic
  • Patent number: 9364643
    Abstract: Some systems and methods for operating a vessel occlusion catheter may include a control and inflation device to control the filling of the balloon in such a manner that the vessel wall will not be overstressed while the safe occlusion of the blood vessel is achieved.
    Type: Grant
    Filed: November 30, 2012
    Date of Patent: June 14, 2016
    Assignee: Miracor Medical Systems GmbH
    Inventors: Jon H. Hoem, Oliver A. Kohr
  • Patent number: 8996106
    Abstract: In a method for the intermittent occlusion of a vein draining the organ system, in which the vein is occluded by an occlusion device, the fluid pressure in the occluded vein is continuously measured and stored, the behavior of the fluid pressure is determined as a function of time, and the occlusion of the vein is triggered and/or released as a function of at least one characteristic value derived from the pressure measurements, pressure is applied during the occlusion in a pulsating manner. The device for the intermittent occlusion of a vein, including an occlusion device, a pressure measuring device for continuously measuring the fluid pressure in the occluded vein, and a memory for storing the fluid pressure behavior as a function of time, means are provided for applying a pulsating pressure in the occluded vein.
    Type: Grant
    Filed: August 5, 2013
    Date of Patent: March 31, 2015
    Assignee: Miracor Medical Systems GmbH
    Inventor: Werner Mohl
  • Patent number: 8801590
    Abstract: In a catheter (2) to assist the performance of a heart (1) with at least one pump (7), the pump is formed as a rotary pump at the distal end of the catheter (2), the rotor (6) lying distally on the outer side being coupled via a magneto coupling with a drive wheel (21), formed as a hydraulically or pneumatically operated paddle wheel, arranged inside the catheter (2). The driving fluid is supplied to the paddle wheel via a lumen (22) of the catheter (2) and is carried off via a further lumen (23) of the catheter.
    Type: Grant
    Filed: July 23, 2012
    Date of Patent: August 12, 2014
    Assignee: Miracor Medical Systems GmbH
    Inventor: Werner Mohl
  • Patent number: 8790265
    Abstract: In a method for intermittently occluding the coronary sinus, in which the coronary sinus is occluded using an occlusion device, the fluid pressure in the occluded coronary sinus is continuously measured and stored, the fluid pressure curve is determined as a function of time, and the occlusion of the coronary sinus is triggered and/or released as a function of at least one characteristic value derived from the measured pressure values. The pressure increase and/or pressure decrease per time unit each occurring at a heart beat are used as characteristic values.
    Type: Grant
    Filed: August 24, 2012
    Date of Patent: July 29, 2014
    Assignee: Miracor Medical Systems GmbH
    Inventors: Werner Mohl, Loay Alzubaidi
  • Patent number: 8715196
    Abstract: In a method for intermittently occluding the coronary sinus, in which in an alternating manner the coronary sinus is occluded by an occlusion device and the occlusion is released, the curve of the fluid pressure occurring in the coronary sinus after the release of the occlusion is estimated by calculation and the time of the beginning of the next occlusion is determined as a function of the estimated pressure curve.
    Type: Grant
    Filed: May 13, 2013
    Date of Patent: May 6, 2014
    Assignee: Miracor Medical Systems GmbH
    Inventors: Werner Mohl, Ilinka Kajgana
  • Patent number: 8667838
    Abstract: Some systems and methods for operating a vessel occlusion catheter may include a control and inflation device to control the filling of the balloon in such a manner that the vessel wall will not be overstressed while the safe occlusion of the blood vessel is achieved.
    Type: Grant
    Filed: November 29, 2012
    Date of Patent: March 11, 2014
    Assignee: Miracor Medical Systems GmbH
    Inventors: Jon H. Hoem, Oliver A. Kohr
  • Patent number: 8646325
    Abstract: Some systems and methods for operating a vessel occlusion catheter may include a control and inflation device to control the filling of the balloon in such a manner that the vessel wall will not be overstressed while the safe occlusion of the blood vessel is achieved.
    Type: Grant
    Filed: May 25, 2010
    Date of Patent: February 11, 2014
    Assignee: Miracor Medical Systems GmbH
    Inventors: Jon H. Hoem, Oliver A. Kohr
  • Patent number: 8628461
    Abstract: A device for the intermittent occlusion of a blood vessel, in particular a vein draining the organ system, comprising an occlusion device which is activatable for intermittent occlusion and positionable in the blood vessel, at least one sensor for the continuous or periodical detection of at least one physiological measurement, and a control device to which the at least one physiological measurement is fed and which cooperates with the occlusion device to control the intermittent occlusion of the blood vessel as a function of said measurement.
    Type: Grant
    Filed: December 22, 2008
    Date of Patent: January 14, 2014
    Assignee: Miracor Medical Systems GmbH
    Inventor: Werner Mohl
  • Patent number: 8626316
    Abstract: In a device for the intermittent occlusion of the coronary sinus, including a catheter with several lumens, an occlusion device fixed to the catheter and operable through at least one lumen of the catheter, and at least one pressure measuring device for measuring the fluid pressure in the coronary sinus, the catheter additionally comprises support means for supporting the catheter on the inner wall of the coronary sinus, which support means are reversibly placeable in abutment on the inner wall of the coronary sinus by an operating element.
    Type: Grant
    Filed: May 14, 2009
    Date of Patent: January 7, 2014
    Assignee: Miracor Medical Systems GmbH
    Inventor: Werner Mohl
  • Publication number: 20130323709
    Abstract: Some embodiments of a system or method for treating heart tissue can include a catheter device that provides a user with the ability to perform a number of heart treatment tasks (before, during, and after a cardiac surgery or a percutaneous coronary intervention). In particular embodiments, the catheter device can be used to (i) precondition heart muscle tissue before the heart is isolated from the circulatory system, (ii) deliver cardioplegia into the coronary sinus during the cardiac surgery when the heart is isolated from the circulatory system, and (iii) control the blood flow through the heart after the heart is reconnected with the circulatory system. In some embodiments, the catheter device can perform some or all of: (i) intermittently occluding the coronary sinus, (ii) delivering a treatment fluid into the coronary sinus, and (iii) monitoring a flow rate of blood passing from the coronary sinus to the right atrium.
    Type: Application
    Filed: August 5, 2013
    Publication date: December 5, 2013
    Applicant: Miracor Medical Systems GmbH
    Inventor: Werner Mohl
  • Publication number: 20130317284
    Abstract: In a method for the intermittent occlusion of a vein draining the organ system, in which the vein is occluded by an occlusion device, the fluid pressure in the occluded vein is continuously measured and stored, the behavior of the fluid pressure is determined as a function of time, and the occlusion of the vein is triggered and/or released as a function of at least one characteristic value derived from the pressure measurements, pressure is applied during the occlusion in a pulsating manner. The device for the intermittent occlusion of a vein, including an occlusion device, a pressure measuring device for continuously measuring the fluid pressure in the occluded vein, and a memory for storing the fluid pressure behavior as a function of time, means are provided for applying a pulsating pressure in the occluded vein.
    Type: Application
    Filed: August 5, 2013
    Publication date: November 28, 2013
    Applicant: Miracor Medical Systems GmbH
    Inventor: Werner Mohl
  • Publication number: 20130253566
    Abstract: In a method for intermittently occluding the coronary sinus, in which in an alternating manner the coronary sinus is occluded by an occlusion device and the occlusion is released, the curve of the fluid pressure occurring in the coronary sinus after the release of the occlusion is estimated by calculation and the time of the beginning of the next occlusion is determined as a function of the estimated pressure curve.
    Type: Application
    Filed: May 13, 2013
    Publication date: September 26, 2013
    Applicant: Miracor Medical Systems GmbH
    Inventors: Werner Mohl, Ilinka Kajgana
  • Patent number: 8500623
    Abstract: In a method for the intermittent occlusion of a vein draining the organ system, in which the vein is occluded by an occlusion device, the fluid pressure in the occluded vein is continuously measured and stored, the behavior of the fluid pressure is determined as a function of time, and the occlusion of the vein is triggered and/or released as a function of at least one characteristic value derived from the pressure measurements, pressure is applied during the occlusion in a pulsating manner. The device for the intermittent occlusion of a vein, including an occlusion device, a pressure measuring device for continuously measuring the fluid pressure in the occluded vein, and a memory for storing the fluid pressure behavior as a function of time, means are provided for applying a pulsating pressure in the occluded vein.
    Type: Grant
    Filed: April 2, 2012
    Date of Patent: August 6, 2013
    Assignee: Miracor Medical Systems GmbH
    Inventor: Werner Mohl
  • Patent number: 8500686
    Abstract: Some embodiments of a system or method for treating heart tissue can include a catheter device that provides a user with the ability to perform a number of heart treatment tasks (before, during, and after a cardiac surgery or a percutaneous coronary intervention). In particular embodiments, the catheter device can be used to (i) precondition heart muscle tissue before the heart is isolated from the circulatory system, (ii) deliver cardioplegia into the coronary sinus during the cardiac surgery when the heart is isolated from the circulatory system, and (iii) control the blood flow through the heart after the heart is reconnected with the circulatory system. In some embodiments, the catheter device can perform some or all of: (i) intermittently occluding the coronary sinus, (ii) delivering a treatment fluid into the coronary sinus, and (iii) monitoring a flow rate of blood passing from the coronary sinus to the right atrium.
    Type: Grant
    Filed: December 5, 2011
    Date of Patent: August 6, 2013
    Assignee: Miracor Medical Systems GmbH
    Inventor: Werner Mohl
  • Patent number: 8500714
    Abstract: Some embodiments of a system or method for treating heart tissue can include a catheter device that provides a user with the ability to perform a number of heart treatment tasks (before, during, and after a cardiac surgery or a percutaneous coronary intervention). In particular embodiments, the catheter device can be used to (i) precondition heart muscle tissue before the heart is isolated from the circulatory system, (ii) deliver cardioplegia into the coronary sinus during the cardiac surgery when the heart is isolated from the circulatory system, and (iii) control the blood flow through the heart after the heart is reconnected with the circulatory system. In some embodiments, the catheter device can perform some or all of: (i) intermittently occluding the coronary sinus, (ii) delivering a treatment fluid into the coronary sinus, and (iii) monitoring a flow rate of blood passing from the coronary sinus to the right atrium.
    Type: Grant
    Filed: December 5, 2011
    Date of Patent: August 6, 2013
    Assignee: Miracor Medical Systems GmbH
    Inventor: Werner Mohl
  • Patent number: 8500685
    Abstract: Some embodiments of a system or method for treating heart tissue can include a catheter device that provides a user with the ability to perform a number of heart treatment tasks (before, during, and after a cardiac surgery or a percutaneous coronary intervention). In particular embodiments, the catheter device can be used to (i) precondition heart muscle tissue before the heart is isolated from the circulatory system, (ii) deliver cardioplegia into the coronary sinus during the cardiac surgery when the heart is isolated from the circulatory system, and (iii) control the blood flow through the heart after the heart is reconnected with the circulatory system. In some embodiments, the catheter device can perform some or all of: (i) intermittently occluding the coronary sinus, (ii) delivering a treatment fluid into the coronary sinus, and (iii) monitoring a flow rate of blood passing from the coronary sinus to the right atrium.
    Type: Grant
    Filed: December 5, 2011
    Date of Patent: August 6, 2013
    Assignee: Miracor Medical Systems GmbH
    Inventor: Werner Mohl